Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
17.6% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
20
users have followed this narrative
New
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.1% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
17
users have liked this narrative
7
users have commented on this narrative
24
users have followed this narrative
9 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
4.7% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
18
users have liked this narrative
7
users have commented on this narrative
22
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
45.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
14
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Arcadia Biosciences
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Zola Distribution Expansion Will Unlock Enduring Market Strength
Key Takeaways Arcadia's focus on expanding Zola distribution and profitable product lines is set to drive revenue growth and improve earnings through high-margin sales. Strategic exits and IP monetization simplify operations, reduce expenses, and provide capital for growth, enhancing long-term financial stability.
View narrative
US$12.00
FV
63.5% undervalued
intrinsic discount
25.66%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
0
users have followed this narrative
7 days ago
author updated this narrative
eEducation Albert
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Restructuring And EdTech Expansion Will Drive Future Success
Key Takeaways Restructuring and cost optimization are key to achieving profitability, with efforts focused on enhancing net margins via operating expense reductions. Strategic international expansion and targeted marketing aim to drive revenue growth by capturing new markets and enhancing user engagement.
View narrative
SEK 5.30
FV
40.4% undervalued
intrinsic discount
2.77%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
7 days ago
author updated this narrative
Ontrak
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Intermountain Health And New Plans Will Redefine Value Care
Key Takeaways Securing new health plan customers and expanding existing ones promises revenue growth as partnerships mature and engagement increases. Transition to a value-based model may improve net margins by aligning incentives with medical cost savings.
View narrative
US$3.00
FV
97.6% undervalued
intrinsic discount
67.05%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
7 days ago
author updated this narrative
Super League Enterprise
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Mobile Gaming And TikTok Will Redefine Digital Media Markets
Key Takeaways Expansion into mobile gaming, new platforms, and AI-driven monetization aims to capture younger audiences and accelerate revenue growth. Operational streamlining and enhanced recurring revenue models position the company for improved margins and earlier profitability.
View narrative
US$30.00
FV
89.0% undervalued
intrinsic discount
15.60%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
7 days ago
author updated this narrative
Actelis Networks
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Federal Certification And SaaS Offerings Will Unlock Smart City Prospects
Key Takeaways Increased federal and military orders, bolstered by key certifications, position Actelis Networks for continued growth impacting future revenue positively. Expansion of software services and strategic infrastructure projects increase revenue predictability and present substantial growth opportunities.
View narrative
US$5.00
FV
90.6% undervalued
intrinsic discount
36.58%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
7 days ago
author updated this narrative
Jaguar Health
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
FDA And EMA Approvals Will Unlock Global Market Potential
Key Takeaways Successful clinical results and regulatory progress could unlock premium pricing, orphan drug exclusivity, and rapid market expansion for crofelemer across multiple rare indications. Strategic partnerships, business development, and traction in underserved specialty and animal health markets enhance long-term earnings potential and reduce reliance on equity funding.
View narrative
US$28.00
FV
93.3% undervalued
intrinsic discount
47.01%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
7 days ago
author updated this narrative
Air Industries Group
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Record 120M Backlog Will Fuel Aerospace And Defense Momentum
Key Takeaways Backlog growth, new contract wins, and global defense spending are set to drive sustained long-term revenue and support gradual earnings stability. Cost-control measures, workforce cuts, and improved balance sheet position the company for stronger profitability as higher-margin orders are fulfilled.
View narrative
US$6.50
FV
53.5% undervalued
intrinsic discount
2.62%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
7 days ago
author updated this narrative
NextEd Group
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Expanding High-Demand Courses Will Strengthen Future Position
Key Takeaways Focus on higher-margin courses and efficient campus utilization is expected to boost revenue and stabilize margins. Expanding in-demand course offerings aligns with trends, potentially enhancing future revenue streams and market position.
View narrative
AU$0.33
FV
32.3% undervalued
intrinsic discount
3.46%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
7 days ago
author updated this narrative
Lifecare
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
TTP Collaboration And Sensor Chemistry Will Streamline Manufacturing
Key Takeaways Strategic partnerships and technological advancements could significantly enhance market position and revenue growth through improved product efficiency and expanded market access. Future European market entry and expected operational cost reductions aim to boost Lifecare's financial stability and allow growth-focused investment.
View narrative
NOK 24.00
FV
58.3% undervalued
intrinsic discount
48.95%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
7 days ago
author updated this narrative
Value any company in seconds
Popular companies